Papers and Presentations
How to Search for Resources
You can search for a variety of content on the CASSS website. CASSS makes available any content with author approval. Narrow your search by using the various filters shown below, such as Resource Type, Event Type, and Year. Refine your search as needed.
Refine Results
Filter By Resource Type
Filter By Event Types
- WCBP (461)
- Cell & Gene Therapy Products (230)
- CMC Strategy Forum Europe (196)
- CE Pharm (187)
- Mass Spectrometry (173)
- Bioassays (134)
- Higher Order Structure (109)
- AT Europe (109)
- CMC Strategy Forum Japan (105)
- CMC Strategy Forum (78)
- CMC Strategy Forum North America Winter (77)
- CMC Strategy Forum North America Summer (61)
- CMC Strategy Forum Latin America (40)
- CGTP Summit (37)
- CMC Strategy Forum China (29)
- Consultants' Network (15)
- CMC Strategy Forum North America Fall (14)
- CGTP Europe (11)
- Symposium on mRNA (11)
- Virtual Summit: Bioconjugates (9)
- Virtual Summit: Manufacturing (8)
- Biophysics Working Group (8)
- Virtual Europe Discussion Group (8)
- CGTP Virtual Summit (7)
- NorCal Regional Forum (6)
- Netherlands Area Biotech Discussion Group (5)
- DC Area Scientific Discussion Group (4)
- Biotech Working Group (2)
- Midwest Regional Forum (2)
- CMC-Vaccines Working Group (1)
Filter By Tags
-
Challenges and Opportunities for Assessing Stability of Emerging Modalities
![System.Collections.Generic.List`1[System.String] Thumbnail](https://www.casss.org/images/default-source/discussion-groups/virtual-europe/dg_120x120_landing_europe.jpg?sfvrsn=b3b1ea67_1)
Speaker Presentation: VEDG 2026Oita Iulia, Ziphius Vaccines, 2026 -
Accelerated Stability Prediction for Biotherapeutic
Speaker Presentation: VEDG 2026Kuzman Drago, Novartis AG, 2026
-
Assessing Stability of Well-Characterized Biotechnology Products
Speaker Presentation: VEDG 2026Blümel Markus, Novartis AG, 2026
-
Accelerating Us Manufacturing Onshoring: Eu Landscape Insights and Innovative Approaches
![System.Collections.Generic.List`1[System.String] Thumbnail](https://www.casss.org/images/default-source/virtual-summit/virtualsummit_120x120_landing.jpg?sfvrsn=20c009bf_2)
Speaker Presentation: Virtual Summit: Manufacturing 2026Kacimi Karim, Novo Nordisk Inc., 2026 -
Ensuring Inspection Success
Speaker Presentation: Virtual Summit: Manufacturing 2026Farbman Mary E., Merck & Co., Inc., 2026
-
Building It Is the Easy Part. Changing the Playbook Is Harder
Speaker Presentation: Virtual Summit: Manufacturing 2026Edwards Julia, Eli Lilly and Company, 2026
-
Post-Approval Changes: Navigating Complexity, Delivering Solutions
Speaker Presentation: Virtual Summit: Manufacturing 2026Cauchon Nina, Amgen Inc., 2026
-
Workforce Capacity & Training: Building the Pipeline for the US Biomanufacturing Wave
Speaker Presentation: Virtual Summit: Manufacturing 2026Auclair Jared, Northeastern University, 2026
-
Regulatory Aspects Introduction - Informational Slides on FDA PreCheck Program
Speaker Presentation: Virtual Summit: Manufacturing 2026Agarabi Cyrus, CDER, FDA, 2026
-
Virtual Summit Manufacturing 2026 Scientific Program
Scientific Program: Virtual Summit Manufacturing 2026
-
Virtual Summit Manufacturing 2026 Summary Infographic
Summary Infographic: Virtual Summit Manufacturing 2026
-
Product Characterization and Role of Your Potency Assays
![System.Collections.Generic.List`1[System.String] Thumbnail](https://www.casss.org/images/default-source/bioassays/bioa2022_120x120_landing_030922e6757b31405d42b082d6f613b63cc9e3.jpg?sfvrsn=b54a1a5f_3)
Roundtable Notes: Session 2 Table 4 Bioassays 2026Product Characterization and Role of Your Potency … -
Platform Methods: Practical Considerations for the Implementation of Updated ICH Q14, ICH Q2, and USP [Session 2]
Roundtable Notes: Session 2 Table 2 Bioassays 2026Platform Methods: Practical Considerations for the …
-
Platform Methods: Practical Considerations for the Implementation of Updated ICH Q14, ICH Q2, and USP
Roundtable Notes: Session 1 Table 2 Bioassays 2026Platform Methods: Practical Considerations for the …
-
Method Comparability Considerations [Session 2]
Roundtable Notes: Session 2 Table 1 Bioassays 2026Method Comparability Considerations
-
Method Comparability Considerations
Roundtable Notes: Session 1 Table 1 Bioassays 2026Method Comparability Considerations
-
Learnings From Bioassay Transfers [Session 2]
Roundtable Notes: Session 2 Table 3 Bioassays 2026Learnings From Bioassay Transfers
-
Learnings From Bioassay Transfers
Roundtable Notes: Session 1 Table 3 Bioassays 2026Learnings From Bioassay Transfers
-
How Can We Enable Career Development for Young Scientists?
Roundtable Notes: Session 2 Table 6 Bioassays 2026How Can We Enable Career Development for Young …
-
Brainstorming on Applications of AI [Session 2]
Roundtable Notes: Session 2 Table 5 Bioassays 2026Brainstorming on Applications of AI